CD138, technical only
Use
CD138 is a transmembrane proteoglycan expressed in various normal and malignant tissues. This protein marker is used to distinguish and quantitate plasma cells in hematolymphoid tissues, and is specifically used as a biomarker for multiple myeloma cells. Technical component only. Pathologist read not included.
Special Instructions
Not provided.
Limitations
Test is technical only; interpretation requires a pathologist. Fixative must be 10% NBF or B plus; other fixatives will be rejected. Specimens not adhering to these conditions may result in rejection or compromised results.
Methodology
Immunoassay (IHC)
Biomarkers
CD138
Protein
Result Turnaround Time
2 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (Fixed (Non-FFPE))
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Fixative should be at a 20:1 fixative to tissue ratio, 10% neutral buffered formalin (NBF) for 6-72 hours (48-72 hours PREFERRED).
Causes for Rejection
Specimens must be fixed in 10% NBF or B plus. All other fixatives will be rejected.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | ≤ 72 Hours |